top of page
Search
Admin
Oct 5, 20173 min read
Cenicriviroc May Reduce Fibrosis In People With Fatty Liver Disease
Cenicriviroc, a drug that blocks both CCR5 and CCR2 receptors on immune cells, was associated with a decrease in liver fibrosis in people...
Admin
Oct 5, 20172 min read
Sofosbuvir Reduces Transplant Need and Mortality Rates in Hepatitis C Patients, Study Finds
Sofosbuvir (sold under the brand name Sovaldi from Gilead Sciences, among others) significantly reduces the risk of death and the need...
Admin
Jul 7, 20171 min read
HIV, Tuberculosis, Hepatitis C: EP proposals for tackling communicable diseases
MEPs urged the Commission on Wednesday to address the increase in HIV/AIDS, tuberculosis and viral hepatitis cases in the EU and to...
Admin
Jun 10, 20172 min read
High Take-Two Cure Rates With Gilead’s New Triple-Drug Hep C Regimen
The fixed-dose combination tablet sofosbuvir/velpatasvir/voxilaprevir provides a good alternative to those who have failed treatment....
Admin
Jun 4, 20171 min read
Hepatitis C Manipulates Liver Cells to Evade an Immune Response
The virus kick-starts a process that blunts the body’s interferon-based immune response. Hepatitis C virus (HCV) helps ensure its...
bottom of page







